|
1
|
Naldini L, Vigna E, Narsimhan RP, Gaudino
G, Zarnegar R, Michalopoulos GK and Comoglio PM: Hepatocyte growth
factor (HGF) stimulates the tyrosine kinase activity of the
receptor encoded by the proto-oncogene c-MET. Oncogene. 6:501–504.
1991.PubMed/NCBI
|
|
2
|
Benvenuti S and Comoglio PM: The MET
receptor tyrosine kinase in invasion and metastasis. J Cell
Physiol. 213:316–325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schoenleber SJ, Kurtz DM, Talwalkar JA,
Roberts LR and Gores GJ: Prognostic role of vascular endothelial
growth factor in hepatocellular carcinoma: systematic review and
meta-analysis. Br J Cancer. 100:1385–1392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seidel C, Børset M, Turesson I, Abildgaard
N, Sundan A and Waage A: Elevated serum concentrations of
hepatocyte growth factor in patients with multiple myeloma. The
Nordic Myeloma Study Group. Blood. 91:806–812. 1998.PubMed/NCBI
|
|
5
|
Toi M, Taniguchi T, Ueno T, Asano M,
Funata N, Sekiguchi K, Iwanari H and Tominaga T: Significance of
circulating hepatocyte growth factor level as a prognostic
indicator in primary breast cancer. Clin Cancer Res. 4:659–664.
1998.PubMed/NCBI
|
|
6
|
Yano S, Wang W, Li Q, Matsumoto K,
Sakurama H, Nakamura T, Ogino H, et al: Hepatocyte growth factor
induces gefitinib resistance of lung adenocarcinoma with epidermal
growth factor receptor-activating mutations. Cancer Res.
68:9479–9487. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kasahara K, Arao T, Sakai K, Matsumoto K,
Sakai A, Kimura H, Sone T, et al: Impact of serum hepatocyte growth
factor on treatment response to epidermal growth factor receptor
tyrosine kinase inhibitors in patients with non-small cell lung
adenocarcinoma. Clin Cancer Res. 16:4616–4624. PubMed/NCBI
|
|
8
|
Miyazawa K, Kitamura A and Kitamura N:
Structural organization and the transcription initiation site of
the human hepatocyte growth factor gene. Biochemistry.
30:9170–9176. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okajima A, Miyazawa K and Kitamura N:
Characterization of the promoter region of the rat
hepatocyte-growth-factor/scatter-factor gene. Eur J Biochem.
213:113–119. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Plaschke-Schlütter A, Behrens J, Gherardi
E and Birchmeier W: Characterization of the scatter
factor/hepatocyte growth factor gene promoter. Positive and
negative regulatory elements direct gene expression to mesenchymal
cells. J Biol Chem. 270:830–836. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma J, DeFrances MC, Zou C, Johnson C,
Ferrell R and Zarnegar R: Somatic mutation and functional
polymorphism of a novel regulatory element in the HGF gene promoter
causes its aberrant expression in human breast cancer. J Clin
Invest. 119:478–491. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishio K, Arioka H, Ishida T, Fukumoto H,
Kurokawa H, Sata M, Ohata M and Saijo N: Enhanced interaction
between tubulin and microtubule-associated protein 2 via inhibition
of MAP kinase and CDC2 kinase by paclitaxel. Int J Cancer.
63:688–693. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawamura-Akiyama Y, Kusaba H, Kanzawa F,
Tamura T, Saijo N and Nishio K: Non-cross resistance of ZD0473 in
acquired cisplatin-resistant lung cancer cell lines. Lung Cancer.
38:43–50. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iwasa T, Okamoto I, Suzuki M, Nakahara T,
Yamanaka K, Hatashita E, Yamada Y, et al: Radiosensitizing effect
of YM155, a novel small-molecule survivin suppressant, in non-small
cell lung cancer cell lines. Clin Cancer Res. 14:6496–6504. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okabe T, Okamoto I, Tamura K, Terashima M,
Yoshida T, Satoh T, Takada M, et al: Differential constitutive
activation of the epidermal growth factor receptor in non-small
cell lung cancer cells bearing EGFR gene mutation and
amplification. Cancer Res. 67:2046–2053. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takezawa K, Okamoto I, Yonesaka K,
Hatashita E, Yamada Y, Fukuoka M and Nakagawa K: Sorafenib inhibits
non-small cell lung cancer cell growth by targeting B-RAF in KRAS
wild-type cells and C-RAF in KRAS mutant cells. Cancer Res.
69:6515–6521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sato M, Takahashi K, Nagayama K, Arai Y,
Ito N, Okada M, Minna JD, et al: Identification of chromosome arm
9p as the most frequent target of homozygous deletions in lung
cancer. Genes Chromosomes Cancer. 44:405–414. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanagihara K, Seyama T, Tsumuraya M,
Kamada N and Yokoro K: Establishment and characterization of human
signet ring cell gastric carcinoma cell lines with amplification of
the c-myc oncogene. Cancer Res. 51:381–386. 1991.PubMed/NCBI
|
|
19
|
Yanagihara K, Tanaka H, Takigahira M, Ino
Y, Yamaguchi Y, Toge T, Sugano K and Hirohashi S: Establishment of
two cell lines from human gastric scirrhous carcinoma that possess
the potential to metastasize spontaneously in nude mice. Cancer
Sci. 95:575–582. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yanagihara K, Takigahira M, Tanaka H, Arao
T, Aoyagi Y, Oda T, Ochiai A and Nishio K: Establishment and
molecular profiling of a novel human pancreatic cancer panel for
5-FU. Cancer Sci. 99:1859–1864. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaneda H, Arao T, Tanaka K, Tamura D,
Aomatsu K, Kudo K, Sakai K, et al: FOXQ1 is overexpressed in
colorectal cancer and enhances tumorigenicity and tumor growth.
Cancer Res. 70:2053–2063. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogunwobi OO, Puszyk W, Dong HJ and Liu C:
Epigenetic upregulation of HGF and c-Met drives metastasis in
hepatocellular carcinoma. PLoS One. 8:e637652013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Onouchi Y, Gunji T, Burns JC, Shimizu C,
Newburger JW, Yashiro M, Nakamura Y, et al: ITPKC functional
polymorphism associated with Kawasaki disease susceptibility and
formation of coronary artery aneurysms. Nat Genet. 40:35–42. 2008.
View Article : Google Scholar
|
|
24
|
Yamada K, Gerber DJ, Iwayama Y, Ohnishi T,
Ohba H, Toyota T, Aruga J, et al: Genetic analysis of the
calcineurin pathway identifies members of the EGR gene family,
specifically EGR3, as potential susceptibility candidates in
schizophrenia. Proc Natl Acad Sci USA. 104:2815–2820. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grotegut S, von Schweinitz D, Christofori
G and Lehembre F: Hepatocyte growth factor induces cell scattering
through MAPK/Egr-1-mediated upregulation of Snail. EMBO J.
25:3534–3545. 2006. View Article : Google Scholar : PubMed/NCBI
|
